找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nutrition and Biotechnology in Heart Disease and Cancer; John B. Longenecker,David Kritchevsky,Marc K. Drez Book 1995 The Editor(s) (if ap

[復(fù)制鏈接]
樓主: 揭發(fā)
21#
發(fā)表于 2025-3-25 04:10:36 | 只看該作者
Louis C. Smith,Randy C. Eisensmith,Savio L. C. Wooaken together, GATA1 plays a key role in regulating megakaryocyte differentiation, maturation, and proliferative capacity. As sequencing and proteomic technologies expand, additional . mutations and regulatory mechanisms contributing to human diseases of megakaryocytes and platelets are likely to be revealed.
22#
發(fā)表于 2025-3-25 11:28:58 | 只看該作者
23#
發(fā)表于 2025-3-25 12:33:36 | 只看該作者
24#
發(fā)表于 2025-3-25 18:20:27 | 只看該作者
25#
發(fā)表于 2025-3-25 23:26:31 | 只看該作者
Daniel Steinbergstrategy for gene therapy as an anti-gene strategy, but is also a powerful tool for the study of endogenous gene regulation in vivo as well as in vitro. In this review, we focus on the future potential of decoy ODN-based therapy.
26#
發(fā)表于 2025-3-26 01:33:06 | 只看該作者
Nutrition and Biotechnology in Heart Disease and Cancer
27#
發(fā)表于 2025-3-26 07:04:05 | 只看該作者
28#
發(fā)表于 2025-3-26 09:41:48 | 只看該作者
resents a powerful tool in basic science, biotechnology and molecular medicine. In this chapter, we will focus on the different approaches followed to design and to deliver artificial zinc finger transcription factors with the final aim of approaching functional genomics, phenotypic engineering and human gene therapy.
29#
發(fā)表于 2025-3-26 14:36:55 | 只看該作者
Steven H. Zeiselor future investigations. E2F activity requires heterodimerization of two partners. Either partner can be one of several different transcription factors; E2Fl, E2F2, E2F3, E2F4, or E2F5 can heterodimerize with either DPl or DP2. Cellular promoters whose E2F sites mediate a link between transcription
30#
發(fā)表于 2025-3-26 19:33:28 | 只看該作者
Bob G. Sanders,Kimberly Klineponses triggered by the various ILC subsets have been linked to inflammatory diseases such as inflammatory bowel disease, atopic dermatitis and airway hyperresponsiveness. Here, we will review recent progress in determining the transcriptional and developmental programs that control ILC fate decisions.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 23:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
淅川县| 扶沟县| 灯塔市| 枞阳县| 兴海县| 犍为县| 廉江市| 莒南县| 龙井市| 安图县| 叙永县| 宝山区| 武威市| 长泰县| 新和县| 东安县| 晋城| 孝感市| 保定市| 汨罗市| 耿马| 建平县| 施甸县| 双辽市| 团风县| 都兰县| 达拉特旗| 惠水县| 呼伦贝尔市| 美姑县| 南投县| 芦溪县| 南澳县| 什邡市| 北川| 焉耆| 施秉县| 扬州市| 孟州市| 昌乐县| 安阳市|